Protein aggregation of alpha-synuclein (α-Syn) is implicated in Parkinson’s disease (PD), and, thus, α-Syn aggregates are a potentially promising candidate biomarker for PD diagnosis. Here, we describe a simple and sensitive electrochemical sensor to monitor the aggregation of α-Syn for early PD diagnosis. The sensor utilizes methylene blue (MB)-tagged aptamer (Apt) adsorbed on electrochemically reduced graphene oxide (ERGO) by π–π stacking. The binding of α-Syn oligomer to the Apt induces desorption of the Apt from the ERGO surface, which leads to the electrochemical signal change. The resulting sensor allowed the highly sensitive and selective detection of α-Syn oligomer according to the voltammetric change. Under optimized conditions, the linear range of detection was observed to be from 1 fM to 1 nM of the α-Syn oligomer and the limit of detection (LOD) was estimated to be 0.64 fM based on S/N = 3. The sensor also showed good reproducibility and stability, enabling real sample analysis of the α-Syn oligomer in human blood serum. With its ultrasensitivity and good performance for α-Syn oligomer detection, the sensor provides one promising tool for the early diagnosis of PD.

In this work, a glassy carbon electrode (GCE) modified with reduced graphene oxide and β-cyclodextrin (rGO/β-CD) nanocomposite was developed for the electrochemical detection of nitrofurantoin (NFT). The structural and morphological characteristics of the synthesized nanocomposite were determined using scanning electron microscopy (SEM), Raman spectroscopy, X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS). Moreover, the electrochemical behavior of the modified electrodes was thoroughly examined using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS), with the rGO/β-CD-modified glassy carbon electrode (GCE) demonstrating superior electron transfer capability. Key experimental parameters, including scan rate, material loading, and solution pH, were systematically optimized. After optimizing the experimental conditions, the modified sensor showed excellent electrocatalytic performance and selectivity toward NFT, achieving a broad linear detection range from 0.5 to 120 μM, a low limit of detection (LOD) of 0.048 μM, and a high sensitivity of 12.1 µA µM^–1 cm^–2 using differential pulse voltammetry (DPV). Furthermore, the fabricated electrode exhibited good anti-interference ability, stability, precision, and real-time applicability for NFT detection in a wastewater sample. These results highlight the potential of the rGO/β-CD nanocomposite as a high-performance platform for electrochemical sensing applications.

We present a novel electrochemical sensor for the detection of alfuzosin (AFZ), an alpha1-adrenoceptor (α₁-AR) antagonist using metal–organic framework (MOF)-derived zinc oxide/cobalt oxide (ZnO/Co₃O₄) decorated on graphene (Gr).

We developed a novel electrochemical sensor for the detection of alfuzosin (AFZ), a drug used to treat benign prostatic hyperplasia, using a double-shelled Co₃O₄/NiCo₂O₄ nanocomposite-modified electrode. The nanocomposites were synthesized using a template-assisted approach, with zeolitic imidazole framework-67 (ZIF-67) as the sacrificial template, involving the formation of uniform ZIF-67/Ni-Co layered double hydroxide (LDH) hollow structures followed by calcination to achieve the final nanocomposite. The nanocomposite was characterized by various techniques and showed high porosity, large surface area, and good conductivity. The nanocomposite-modified electrode exhibited excellent electrocatalytic activity towards AFZ oxidation, with a wide linear range of 5–180 µM and a low limit of detection of 1.37 µM. The sensor also demonstrated good repeatability, reproducibility, and stability selectivity in the presence of common interfering substances. The sensor was successfully applied to determine the AFZ in pharmaceutical tablets and human serum samples, with satisfactory recoveries. Our results suggest that the double-shelled Co₃O₄/NiCo₂O₄ nanocomposite is a promising material for the fabrication of electrochemical sensors for AFZ detection.

Silver ions (Ag⁺) are crucial in various fields, but pose environmental and health risks at high concentrations. This study presents a straightforward approach for the ultra-trace detection of Ag⁺, utilizing a composite of a cytosine-rich oligonucleotide (CRO) and an electrochemically reduced graphene oxide (ERGO). Initially, ERGO was synthesized on a glassy carbon electrode (GCE) through the reduction of graphene oxide (GO) via cyclic voltammetry. A methylene blue-tagged CRO (MB-CRO) was then anchored to the ERGO surface through π–π interactions, resulting in the formation of an MB-CRO-modified ERGO electrode (MB-CRO/ERGO-GCE). The interaction with Ag⁺ ions induced the formation of silver-mediated C-Ag⁺-C coordination, prompting the MB-CRO to adopt a hairpin structure. This conformational change led to the desorption of the MB-CRO from the ERGO-GCE, causing a variation in the redox current of the methylene blue associated with the MB-CRO. Electrochemical assays revealed that the sensor exhibits extraordinary sensitivity to Ag+ ions, with a linear detection range from 1 femtomolar (fM) to 100 nanomolars (nM) and a detection limit of 0.83 fM. Moreover, the sensor demonstrated high selectivity for Ag⁺ ions and several other benefits, including stability, reproducibility, and straightforward fabrication and operational procedures. Additionally, real sample analyses were performed using the modified electrode to detect Ag⁺ in tap and pond water samples, yielding satisfactory recovery rates.